Skip to main content
. 2014 Dec 15;5(1):354–362.

Figure 3.

Figure 3

Follow up of bcr/abl levels in patients with normal and elevated serum tryptase levels. The bcr/abl levels decresed markedly in both, patients with normal (filled boxes) and elevated serum tryptase levels (empty boxes). However, The differences between the two groups with regard to transcript levels of bcr/abl observed at 6, 9 and 12 months were found to be statistically significant (p<0.05).